Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Rospond

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Practice|March 25, 2000
A new transmucosal fentanyl for breakthrough cancer painR M Rospond
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|November 1, 1996
Cancer-related issues for womenR M Rospond
AORN Journal|March 1, 1995
Hepatic artery chemoembolization therapy for hepatic tumorsR M Rospond, W Mills
Hospital Pharmacy|September 1, 1991
Biotechnology--1991R M Rospond, T T Do
American Journal of Hospital Pharmacy|October 1, 1993
Obtaining reimbursement for oncology pharmacy services provided to ambulatory patientsS F Chong, R M Rospond
Clinical Pharmacy|August 1, 1993
Dimethyl sulfoxide for treating anthracycline extravasationR M Rospond, L M Engel
American Journal of Hospital Pharmacy|February 1, 1992
Use of p.r.n. medications in oncology patients at a university teaching hospitalR M Jones, R M Rospond, S F Chong
Clinical Pharmacy|March 1, 1993
Sargramostim for sulfasalazine-induced agranulocytosisR M Rospond, R C Glowacki, J A Mailliard
Clinical Pharmacokinetics|January 1, 1993
Aminoglycoside forecasting in neutropenic patients with cancerJ L Kosirog, R M Rospond, C Destache, et al.
Pharmacotherapy|January 1, 1989
Evaluation of factors associated with stability of anticoagulation therapyR M Rospond, C M Quandt, G M Clark, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Practice|March 25, 2000
A new transmucosal fentanyl for breakthrough cancer painR M Rospond
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|November 1, 1996
Cancer-related issues for womenR M Rospond
AORN Journal|March 1, 1995
Hepatic artery chemoembolization therapy for hepatic tumorsR M Rospond, W Mills
Hospital Pharmacy|September 1, 1991
Biotechnology--1991R M Rospond, T T Do
American Journal of Hospital Pharmacy|October 1, 1993
Obtaining reimbursement for oncology pharmacy services provided to ambulatory patientsS F Chong, R M Rospond
Clinical Pharmacy|August 1, 1993
Dimethyl sulfoxide for treating anthracycline extravasationR M Rospond, L M Engel
American Journal of Hospital Pharmacy|February 1, 1992
Use of p.r.n. medications in oncology patients at a university teaching hospitalR M Jones, R M Rospond, S F Chong
Clinical Pharmacy|March 1, 1993
Sargramostim for sulfasalazine-induced agranulocytosisR M Rospond, R C Glowacki, J A Mailliard
Clinical Pharmacokinetics|January 1, 1993
Aminoglycoside forecasting in neutropenic patients with cancerJ L Kosirog, R M Rospond, C Destache, et al.
Pharmacotherapy|January 1, 1989
Evaluation of factors associated with stability of anticoagulation therapyR M Rospond, C M Quandt, G M Clark, et al.
Pageof 2